Search Results - "Hair, M."

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis by Hair, M. J. H., Sande, M. G. H., Ramwadhdoebe, T. H., Hansson, M., Landewé, R., Leij, C., Maas, M., Serre, G., Schaardenburg, D., Klareskog, L., Gerlag, D. M., Baarsen, L. G. M., Tak, P. P.

“…Objective Findings from previous studies have suggested that subclinical inflammation of the synovium does not coincide with the appearance of rheumatoid…”
Get full text

Combined exposure to lead, cadmium, mercury, and arsenic and kidney health in adolescents age 12–19 in NHANES 2009–2014 by Sanders, Alison P., Mazzella, Matthew J., Malin, Ashley J., Hair, Gleicy M., Busgang, Stefanie A., Saland, Jeffrey M., Curtin, Paul

“…Occupational and environmental exposures to toxic metals are established risk factors for the development of hypertension and kidney disease in adults. There…”
Get full text

Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase by van de Sande, M G H, de Hair, M J H, van der Leij, C, Klarenbeek, P L, Bos, W H, Smith, M D, Maas, M, de Vries, N, van Schaardenburg, D, Dijkmans, B A C, Gerlag, D M, Tak, P P

“…The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disorder, is poorly understood. It is currently unknown whether the…”
Get more information

Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study by Gerlag, Danielle M, Safy, Mary, Maijer, Karen I, Tang, Man Wai, Tas, Sander W, Starmans-Kool, Mirian J F, van Tubergen, Astrid, Janssen, Matthijs, de Hair, Maria, Hansson, Monika, de Vries, Niek, Zwinderman, Aeilko H, Tak, Paul P

“…We explored the effects of B-cell directed therapy in subjects at risk of developing autoantibodypositive rheumatoid arthritis (RA), who never experienced…”
Get more information

Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review by Safy, M, de Hair, M J H, Jacobs, J W G, Buttgereit, F, Kraan, M C, van Laar, J M

“…Long-term treatment with glucocorticoids (GCs) plays an important role in the management of arthritis patients, although the efficacy/safety balance is…”
Get full text

Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease by Klarenbeek, P L, de Hair, M J H, Doorenspleet, M E, van Schaik, B D C, Esveldt, R E E, van de Sande, M G H, Cantaert, T, Gerlag, D M, Baeten, D, van Kampen, A H C, Baas, F, Tak, P P, de Vries, N

“…To profile quantitatively the T-cell repertoire in multiple joints and peripheral blood of patients with recent onset (early) or established rheumatoid…”
Get more information

Optogenetic control of Bacillus subtilis gene expression by Castillo-Hair, Sebastian M., Baerman, Elliot A., Fujita, Masaya, Igoshin, Oleg A., Tabor, Jeffrey J.

“…The Gram-positive bacterium Bacillus subtilis exhibits complex spatial and temporal gene expression signals. Although optogenetic tools are ideal for studying…”
Get full text

Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity by Doorenspleet, M E, Klarenbeek, P L, de Hair, M J H, van Schaik, B D C, Esveldt, R E E, van Kampen, A H C, Gerlag, D M, Musters, A, Baas, F, Tak, P P, de Vries, N

“…To identify potential autoreactive B-cell and plasma-cell clones by quantitatively analysing the complete human B-cell receptor (BCR) repertoire in synovium…”
Get more information

Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: A population based analysis from a Scottish region by Collier, A, Ghosh, S, Hair, M, Waugh, N

“…Abstract Aims In this cross-sectional study, the aims were to investigate the association of the socioeconomic status and gender on the prevalence of type 1…”
Get full text

Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births by Fritsch-Stork, R. D. E., van Laar, J. M., Lely, A. T., Limper, M., de Hair, M. J. H., Kroese, S. J., Derksen, R. H. W. M.

“…Objective. To investigate the effect of hydroxychloroquine (HCQ) in pregnant women with systemic lupus erythematosus (SLE). Methods. In SLE pregnancies of a…”
Get full text

Comparative pathogenicity of Malaysian variant and very virulent infectious bursal disease viruses in chickens by Aliyu, H. B., Hamisu, T. M., Hair Bejo, M., Omar, A. R., Ideris, A.

“…Variant infectious bursal disease virus (vaIBDV) has been identified in various countries with significant economic losses. Recently, the first identification…”
Get full text

The clinical picture of rheumatoid arthritis according to the 2010 American College of Rheumatology/European League Against Rheumatism criteria: Is this still the same disease? by de Hair, M. J. H., Lehmann, K. A., van de Sande, M. G. H., Maijer, K. I., Gerlag, D. M., Tak, P. P.

“…Objective To examine the implications of using the new classification criteria for rheumatoid arthritis (RA) in clinical practice in a cohort of patients with…”
Get full text

An open-hardware platform for optogenetics and photobiology by Gerhardt, Karl P., Olson, Evan J., Castillo-Hair, Sebastian M., Hartsough, Lucas A., Landry, Brian P., Ekness, Felix, Yokoo, Rayka, Gomez, Eric J., Ramakrishnan, Prabha, Suh, Junghae, Savage, David F., Tabor, Jeffrey J.

“…In optogenetics, researchers use light and genetically encoded photoreceptors to control biological processes with unmatched precision. However, outside of…”
Get full text

Corrigendum to “Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births” by Kroese, S. J., de Hair, M. J. H., Limper, M., Lely, A. T., van Laar, J. M., Derksen, R. H. W. M., Fritsch-Stork, R. D. E.

“…[This corrects the article DOI: 10.1155/2017/2810202.]…”
Get full text

The novel use of Sentimag to localise metallic foreign bodies in soft tissue by Kong, C Y, Apollos, J, Bews-Hair, M

Get full text

Gender differences and patterns of cardiovascular risk factors in Type 1 and Type 2 diabetes: a population-based analysis from a Scottish region by Collier, A., Ghosh, S., Hair, M., Waugh, N.

“…Aim To explore the gender differences, along with the relationships between BMI, glycaemic control, cardiovascular risk factors and the prevalence of diabetes…”
Get full text

The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial by Jurgens, M S, Safy-Khan, M, de Hair, M J H, Bijlsma, J W J, Welsing, P M J, Tekstra, J, Lafeber, F P J G, Sasso, E H, Jacobs, J W G

“…The CAMERA-II trial compared two tight-control, treat-to-target strategies, initiating methotrexate with prednisone (MTX+pred) or MTX with placebo (MTX+plac),…”
Get full text

The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis by van Baarsen, L G M, de Hair, M J H, Ramwadhdoebe, T H, Zijlstra, I J A J, Maas, M, Gerlag, D M, Tak, P P

“…Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease of unknown aetiology. Recent work has shown that systemic autoimmunity precedes synovial…”
Get more information

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma by Black, Christopher M, Hanna, Glenn J, Wang, Liya, Ramakrishnan, Karthik, Goto, Daisuke, Turzhitsky, Vladimir, Hair, Gleicy M

“…Pembrolizumab, a PD-1 immune checkpoint inhibitor, is approved as first-line (1L) treatment for recurrent or metastatic head and neck squamous cell carcinoma…”
Get full text

Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma by Black, Christopher M, Zheng, Dandan, Hair, Gleicy M, Ai, Lei, Wang, Liya, Goto, Daisuke, Lerman, Nati, Bidadi, Behzad, Hanna, Glenn J

“…The programmed death-1 (PD-1) immune checkpoint inhibitor pembrolizumab is currently approved in the US for the first-line (1L) treatment of recurrent or…”
Get full text